UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): June 1, 2017
DS HEALTHCARE GROUP, INC.
(Exact name of registrant as specified in its charter)
______________
| | | | |
Florida | | 001-35763 | | 20-8380461 |
(State or Other Jurisdiction
of Incorporation or Organization) | | (Commission
File Number) | | (I.R.S. Employer
Identification No.) |
1601 Green Road, Pompano Beach, Florida 33064
(Address of Principal Executive Office) (Zip Code)
(888) 404-7770
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
———————
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
| |
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
| |
Emerging growth company ¨ | |
If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
POMPANO BEACH, FL June 2, 2017 /DS Healthcare Group (DSKX).On June 1, 2017 the Board of Directors of DS Healthcare Group, Inc. (the “Company”) received notice that Daniel Khesin was resigning as a Director from the Board of Directors and as CEO and President of the company. Mr. Khesin will remain an employee, but no longer be an officer or director of the company. He will have the title of Founder and Innovator, spearheading initiatives in product research and development. Yasuhiro Fujiwara has been appointed CEO of DS Healthcare Group effective immediately. Mr. Fujiwara has resigned as Chairman and Elina Yuabov has been appointed Chairperson.
Item 9.01 - Financial Statement and Exhibits
(d)
Exhibits
99.1
Press Release issued June 5, 2017
99.2
Contract – Yasuhiro Fujiwara
99.3
Contract – Daniel Khesin
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | |
| DS HEALTHCARE GROUP, INC. | |
| | | |
Date: June 5, 2017 | By: | /s/John Power | |
| | John Power | |
| | Chief Financial Officer | |
